BeamMed Inc. products

Omnipath™ is a unique, patented, proprietary axial transmission technology based on the measurement of the speed of ultrasonic waves propagating along the bone. A breakthrough technology that is implemented in Sunlight MiniOmni and Omnisense™ devices, Omnipath enables measurement along the bone’s maximal strength axis, eliminating soft tissue effects and providing better accuracy and precision of measurement. Axially transmitted speed of sound (SOS) indicates overall bone strength by reflecting properties such as mineral density, elasticity, cortical thickness and microstructure.

Sunlight MiniOmni and Omnisense™ are currently the only bone sonometers on the market that can measure at multiple skeletal sites. Multi-site testing provides a better chance of identifying individual cases of osteoporosis as well as enabling flexibility in testing patients who cannot be tested at a particular skeletal site. Multi-site measurement also has advantages in monitoring treatment results, because different bones may respond to treatment at different rates.